0
0,00
Mini Cart
  • Empty cart

    No products in the cart.

Olimpiq SXC B 200% Specialized (250pcs)

Olimpiq SXC B 200% Specialized (250pcs)

261,69

100% more stem cells!
1 component:
Capsule “B” – Stem Cell Increasing Component (SXC).
The use of the preparation is recommended for the permanent and continuous increase of the number of stem cells in the circulating blood, which is demonstrably decreasing, for the improvement of the defensive and regenerative capacity of the degenerated organism, and for the increase of its performance.

Description

100% more stem cells!
Component 1:
Capsule B –  Stem Cell Increasing Component (SXC) .

It is recommended for use in case of decreasing regenerative capacity of the body related to age, oxidative stress and the impact of adverse environmental factors, for a lasting and continuous increase in the number of stem cells in the circulating blood, for a permanent and continuous increase in the protective and regenerative to improve its ability and increase its performance.

Stem cell:

A stem cell is a non-specialized cell capable of an unlimited number of divisions, self-renewal,  which forms cells similar to itself through symmetrical division, and also creates committed progeny cells.
The most important property of stem cells is that they can transform into any tissue cell, even general regenerating cells.

We distinguish two types of stem cells, embryonic and adult stem cells.  Embryonic stem cells can be derived from bladder germ formed during cell division for 14 days after fertilization. Adult stem cells are found in our tissues, and they are formed and stored in the bone marrow.

If an organ is not functioning optimally or is damaged in some way and needs cell replacement, it sends a message to the bone marrow that recognizes the information and sends stem cells to the damaged area. This is called the general regeneration mechanism of the body.

This process can be modeled as follows:

– The stem cell exits the bone marrow.
– It gets into the bloodstream.
– It reaches the organs with the help of a special messenger material.
– When he arrives at the “target area”, he takes advantage of his ability to divide and forwards his copy, and he himself integrates and becomes the cells of the organ.

It can be said that the decrease in the number of stem cells is an accurate physiological indicator of the lack of regeneration and aging.

The physical activity of the circulating stem cell number can also be increased by consuming certain foods. A simple and convenient way to do this is to consume the Olimpiq SXC product, which was developed at the Medical University of Pécs and can increase the stem cell level of peripheral blood by up to 200% based on research.

In terms of its mechanism of action, after consumption, it inspires bone marrow stem cell-producing and storage tissues to release more adult multipotent stem cells into the bloodstream. In this way, the excess stem cells are able to regenerate our worn out cells. Two hours after consumption, a 175% increase in blood samples can be detected.

This version
of Olimpiq SXC consists of one component: The Olimpiq SXC component affects bone marrow cell production. This component is responsible for increasing the number of stem cells in the bloodstream.

Olimpiq SXC research results:

In case of diabetes:
Hungarian researchers artificially damaged the so-called insulin-producing insulin in the pancreas of experimental animals. beta cells and then one group was fed Olimpiq SXC with their normal diet. It can be seen from Figure 1 that insulin production was significantly improved in animals consuming Olimpiq SXC compared to the control group. It is likely that the damaged tissue cells were replaced by plus-produced stem cells and insulin production was restored. The form of Olimpiq SXC developed for diabetics is Olimpiq SXC SL (Sugar Level).

Department of Pharmacology, University of Medicine and Pharmacy Targu Mures, 2. Ophthalmology Clinic, Targu Mures, 3. Department of Pathology, University of Medicine and Pharmacy, Targu Mures, 4. Department of Public Health, University of Pecs, Hungary, 5. Crystal Institute KFT, Eger, Hungary. Doczi-Keresztesi Z. 1, 2, Jung J. 3, Kiss I. 4, Mezei T. 3 Szabo L. 5, Ember I. 4

Subject:  To determine whether treatment with the long-term cell stimulant Olimpiq SXC SL prevents hyperglycemically induced retinal and renal vascular permeability and blood-retinal barrier arrest (BRB) in alloxan-induced diabetics.

Methods:  Male Whistar rats were divided into three groups. Two groups received a single intraperitoneal injection of Alloxan (125 mg / kg) – a substance that is a pancreatic beta cell toxicant; another group received solvent / vehicle. One group of Alloxane-excited diabetic rats was treated with Olimpiq SXC SL for 4 weeks, while the untreated and non-diabetic control groups were fed standard laboratory diet. Blood-retinal barrier and renal vascular permeability were measured by fluorescein isothiocyanate permeation, which was labeled with calf serum albumin (FITC-BSA).

Results:
 At 6 weeks after treatment with alloxan, significant tissue fluorescence occurred, renal vascular leakage, and BRB collapse were detected in the diabetic group compared to the non-diabetic group. Olimpiq SXC SL treatment significantly reduced BRB collapse, tissue fluorescence, and vascular leakage compared with the untreated group.

The mechanism of these effects may include regeneration of the vascular endothelium induced by stem cell stimulation. Blood glucose values ​​gradually decreased without significant differences between groups, hence no insulin-secreting beta cell regeneration could be detected.

Blood glucose levels on a continuous diet with Olimpiq SXC started concomitantly with Alloxan

Conclusion:  The results suggest that Olimpiq SXC SL may be useful in the treatment of diabetic complications such as kidney disease or retinal disease, which are associated with increased vascular permeability.

Other research findings:

Patients have lower cardiovascular mortality:

The number of CD34 + KDR + endothelial progenitor cells (EPS) was determined in 519 patients with coronary artery disease confirmed by angiography. Patients received standard medical treatment and then, after 12 months, the effectiveness of the therapy was compared with the level of EPS measured before starting treatment. Patients with higher circulating EPS concentrations had lower cardiovascular mortality, longer event-free survival, fewer patients in this group had to be hospitalized, and revascularization was also faster (all results were statistically significant) than patients with initially lower stem cell counts. Patients with higher circulating EPS concentrations had lower cardiovascular mortality and longer event-free survival.
Source: Circulating endothelial progenitor cells and cardiovascular outcomes. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. N Engl J Med. 2005 Sep 8; 353 (10): 999-1007.

The study looked at 176 different patients with headaches, looking for a correlation between the number of circulating endothelial progenitor cells on the one hand and their function on the other. The study found that EPS numbers were significantly lower in migraine patients and that EP cells also showed functional abnormalities (e.g., reduced migration capacity).
Source: Decreased number and function of endothelial progenitor cells in patients with migraine. Lee ST, Chu K, Jung KH et al. Neurology. 2008 Apr 22; 70 (17): 1510-7.

Erections and Erectile
Dysfunction : The authors studied and compared 30 patients with overweight erectile dysfunction with the same number of healthy controls of the same age and weight but without erectile dysfunction. Concentrations of CD34 + KDR + EP cells were lower in patients with erectile dysfunction than in healthy controls. The decrease in EPS number correlated with the severity of erectile dysfunction.
Source: Circulating CD34 + KDR + endothelial progenitor cells correlate with erectile function and endothelial function in overweight men. Esposito K, Ciotola M, Maiorino MI, Giugliano F, Autorino R, De Sio M, Jannini E, Lenzi A, Giugliano D. J Sex Med. 2009 Jan; 6 (1): 107-14.

45 patients in need of ventilation were studied:
The authors studied patients in need of artificial respiration with acute respiratory distress (45 individuals) to determine whether there is a relationship between patients ’stem cell concentration (endothelial progenitor cells) and disease prognosis. The results showed that patients with low EPS had twice the mortality (61%) of those with higher EPS (30% mortality). The correlation can be said to be statistically significant.
Source: Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. Am J RespirCrit Care Med. 2005 Oct 1; 172 (7): 854-60.

Stroke versus stem cell level:
The authors studied the number of EP cells in stroke patients. It was found that patients with acute stroke had lower EP cell counts than those with chronic stroke or healthy individuals. There was also a lower EP cell count in patients with severe atherosclerosis — the cause of storke (compared with embolism-induced strokes).
Source: Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Chu K, Jung KH, Lee ST et al. Stroke. 2008 May; 39 (5): 1441-7.

Hypertension and stem cells:
The authors studied 37 patients with refractory hypertension and 30 normotensive controls, comparing their EPS concentrations. The number of EPS in patients with refractory hypertension was 56% lower than in the healthy control group, and this was an independent association independent of all other known risk factors.
Source: Endothelial progenitor cells are reduced in refractory hypertension. Oliveras A, Soler MJ, Martínez-Estrada OM et al. J Hum Hypertens. 2008 Mar; 22 (3): 183-90.

Stem cell levels in kidney patients:

By examining 50 chronic kidney patients, the authors concluded that chronic kidney disease reduces the number of circulating EP cells, which may contribute to the consequently increased cardiovascular risks. They warn that dialysis removes abnormal metabolites but does not normalize the circulating EPS, so cardiovascular risk remains elevated despite dialysis.
Source: Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Krenning G, Dankers PY, DrouvenJW Am J Physiol Renal Physiol. 2009 Jun; 296 (6): F1314-22.

Ingredients:
Dried Hemp Seed Grind, L-Carnitine, Ganoderma Lucidum Dried Grind, Corn Mustache Dried Grind, Coenzyme Q10, Afa Algae Powder, Spirulina Algae Powder, Chlorophyll, Lithium Fruit Dried Grind, Fucoidan Dried Algae, Brown Algae Extract (Brown Algae) -arginine, capsule: gelatin, dye: titanium dioxide, red iron oxide, indigo carmine.

Nutritional value and active ingredients:

1 capsule
Energy content 4.24 kJ (1.01 kcal)
Protein 0.2 g
Carbohydrate 0.12 g
Sugar 0.1 g
Fat 0.03 g
Saturated fatty acids 0.03 g
Fiber 0.06 g
Sodium 0
Hemp seeds 71.8 mg
Ganoderma Lucidum 50 mg
L-carnitine
L-arginine
70 mg
3.2 mg
Coenzyme Q10 5 mg
NADH 5 mg

Recommended use:
– 1 capsule B (stem cell increasing component) every 1-2 days. If required, 2×1 B capsules can be taken daily.

Pack sizes:
– 100 capsules, 250 capsules.